Outcome of patients with occlusions of the internal carotid artery or the main stem of the middle cerebral artery with NIHSS score of less than 5: comparison between thrombolysed and non-thrombolysed patients

Barber, 2001, Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility, Neurology, 56, 1015, 10.1212/WNL.56.8.1015

Wendt, 2013, Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores, J Stroke Cerebrovasc Dis, 22, 550, 10.1016/j.jstrokecerebrovasdis.2013.01.021

Cocho, 2005, Reasons for exclusion from thrombolytic therapy following acute ischemic stroke, Neurology, 64, 719, 10.1212/01.WNL.0000152041.20486.2F

Willey, 2012, Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms, Int J Stroke, 7, 202, 10.1111/j.1747-4949.2011.00696.x

Park, 2013, Validation of minor stroke definitions for thrombolysis decision making, J Stroke Cerebrovasc Dis, 22, 482, 10.1016/j.jstrokecerebrovasdis.2013.03.006

Smith, 2011, Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke, Stroke, 42, 3110, 10.1161/STROKEAHA.111.613208

Smith, 2005, Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke, Stroke, 36, 2497, 10.1161/01.STR.0000185798.78817.f3

Johnston, 2003, Early recovery after cerebral ischemia risk of subsequent neurological deterioration, Ann Neurol, 54, 439, 10.1002/ana.10678

Rajajaee, 2006, Early MRI and outcomes of untreated patients with mild or improving ischemic stroke, Neurology, 67, 980, 10.1212/01.wnl.0000237520.88777.71

Nedeltchew, 2007, Outcome of stroke with mild or rapidly improving symptoms, Stroke, 38, 2531, 10.1161/STROKEAHA.107.482554

Alexandrov, 2000, Deterioration following spontaneous improvement: sonographic findings in patients with acutely resolving symptoms of cerebral ischemia, Stroke, 31, 915, 10.1161/01.STR.31.4.915

Easton, 2009, Definition and evaluation of transient ischemic attack. A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease, Stroke, 40, 2276, 10.1161/STROKEAHA.108.192218

Lyden, 1994, Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group, Stroke, 25, 2220, 10.1161/01.STR.25.11.2220

Adams, 1999, Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST), Neurology, 53, 126, 10.1212/WNL.53.1.126

Hacke, 2004, Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials, Lancet, 363, 768, 10.1016/S0140-6736(04)15692-4

Furlan, 1999, Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism, JAMA, 282, 2003, 10.1001/jama.282.21.2003

Nogueira, 2012, Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial, Lancet, 380, 1231, 10.1016/S0140-6736(12)61299-9

Fischer, 2013, Endovascular therapy in 201 patients with acute symptomatic occlusion of the internal carotid artery, Eur J Neurol, 20, 1017, 10.1111/ene.12094

Dhamoon, 2009, Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study, Stroke, 40, 2805, 10.1161/STROKEAHA.109.549576

Jauch, 2013, Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 44, 870, 10.1161/STR.0b013e318284056a

Köhrmann, 2009, Safety and outcome after thrombolysis in stroke patients with mild symptoms, Cerebrovasc Dis, 27, 160, 10.1159/000185607

Baumann, 2006, Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms, Stroke, 37, 1332, 10.1161/01.STR.0000217272.38455.a2

Logallo, 2014, Mild stroke: safety and outcome in patients receiving thrombolysis, Acta Neurol Scand Suppl, 198, 37, 10.1111/ane.12235

National Institute of Neurological Disorders Stroke rtPA Stroke Study Group, 2005, Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience, Ann Emerg Med, 46, 243, 10.1016/j.annemergmed.2005.02.013

Steffenhagen, 2009, Should you thrombolyse all or any stroke patients with baseline National Institutes of Health stroke scale scores < or=5?, Cerebrovasc Dis, 28, 201, 10.1159/000226579

Greisenegger, 2014, Thrombolysis in patients with mild stroke: results from the Austrian Stroke Unit Registry, Stroke, 45, 765, 10.1161/STROKEAHA.113.003827

Seners, 2014, Unexplained early neurological deterioration after intravenous thrombolysis: incidence, predictors, and associated factors, Stroke, 45, 2004, 10.1161/STROKEAHA.114.005426